Skip to main content
. 2022 Nov 9;12:1061513. doi: 10.3389/fonc.2022.1061513

Figure 2.

Figure 2

Survival analysis of patients treated with APR (APR group) and patients who did not receive APR (no-APR group). (log-rank test; p=0.321).